Pacific Research Network

San Diego, California 92128

1 studies enrolling now · 48 studies all time

What they study most

Acute Pain, Age-Related Cognitive Decline, Age-Related Memory Disorders, Alzheimer Disease, Alzheimer Disease (AD), Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia, Cataplexy Narcolepsy, Cognition Disorders, Depression, Essential Tremor, Excessive Daytime Sleepiness

Studies at this site

• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• XG005 for Pain Control in Subjects Undergoing Bunionectomy — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA) — Completed
• Bryostatin Treatment of Moderately Severe Alzheimer's Disease — Completed
• Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old — Completed
• A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) — Stopped early
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy — Completed
• AD109 Dose Finding in Mild to Moderate OSA — Completed
• Parallel Arm Trial of AD109 and AD504 In Patients With OSA — Completed
• A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease — Paused
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy — Completed
• Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• A Phase 2 RCT Study of CX-8998 for Essential Tremor — Completed
• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS — Status unconfirmed
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy — Completed
• A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease — Completed
• A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease — Completed
• 18F-AV-1451 Autopsy Study — Completed
• Tau Screening Study in Patients With Early Symptomatic AD — Completed
• A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia — Status unconfirmed
• A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 — Completed
• A Multiple Ascending Dose Study of COR388 — Completed
• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials — Completed
• Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease — Completed
• A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease — Stopped early
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Valproate in Dementia (VALID) — Completed
• DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease — Completed
• Memory Improvement With Docosahexaenoic Acid Study (MIDAS) — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease — Completed
• Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed
• The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease — Completed
• The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease — Stopped early
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) — Completed